210 related articles for article (PubMed ID: 28161143)
1. Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region.
Hand DJ; Short VL; Abatemarco DJ
J Subst Abuse Treat; 2017 May; 76():58-63. PubMed ID: 28161143
[TBL] [Abstract][Full Text] [Related]
2. Trends and disparities in receipt of pharmacotherapy among pregnant women in publically funded treatment programs for opioid use disorder in the United States.
Short VL; Hand DJ; MacAfee L; Abatemarco DJ; Terplan M
J Subst Abuse Treat; 2018 Jun; 89():67-74. PubMed ID: 29706175
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with receipt of medication for opioid use disorder among pregnant individuals entering treatment programs in the U.S.
Curran L; Manuel J
Int J Drug Policy; 2024 Apr; 126():104342. PubMed ID: 38479161
[TBL] [Abstract][Full Text] [Related]
4. Association of Pregnancy and Insurance Status With Treatment Access for Opioid Use Disorder.
Patrick SW; Richards MR; Dupont WD; McNeer E; Buntin MB; Martin PR; Davis MM; Davis CS; Hartmann KE; Leech AA; Lovell KS; Stein BD; Cooper WO
JAMA Netw Open; 2020 Aug; 3(8):e2013456. PubMed ID: 32797175
[TBL] [Abstract][Full Text] [Related]
5. Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.
Bachhuber MA; Mehta PK; Faherty LJ; Saloner B
Med Care; 2017 Dec; 55(12):985-990. PubMed ID: 29135769
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with buprenorphine versus methadone use in pregnancy.
Krans EE; Bogen D; Richardson G; Park SY; Dunn SL; Day N
Subst Abus; 2016; 37(4):550-557. PubMed ID: 26914546
[TBL] [Abstract][Full Text] [Related]
7. Association of Criminal Statutes for Opioid Use Disorder With Prevalence and Treatment Among Pregnant Women With Commercial Insurance in the United States.
Gressler LE; Shah S; Shaya FT
JAMA Netw Open; 2019 Mar; 2(3):e190338. PubMed ID: 30848807
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Initiation of Medication for Opioid Use Disorder and Retention in Treatment Among U.S. Pregnant Women, 2013-2017.
Nguemeni Tiako MJ; Friedman A; Culhane J; South E; Meisel ZF
Obstet Gynecol; 2021 Apr; 137(4):687-694. PubMed ID: 33706349
[TBL] [Abstract][Full Text] [Related]
9. A Moral or Medical Problem? The Relationship between Legal Penalties and Treatment Practices for Opioid Use Disorders in Pregnant Women.
Angelotta C; Weiss CJ; Angelotta JW; Friedman RA
Womens Health Issues; 2016; 26(6):595-601. PubMed ID: 27773527
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of drug use among pregnant women in the United States: Opioid and non-opioid illegal drug use.
Metz VE; Brown QL; Martins SS; Palamar JJ
Drug Alcohol Depend; 2018 Feb; 183():261-266. PubMed ID: 29310077
[TBL] [Abstract][Full Text] [Related]
11. Medical marijuana laws are associated with increases in substance use treatment admissions by pregnant women.
Meinhofer A; Witman A; Murphy SM; Bao Y
Addiction; 2019 Sep; 114(9):1593-1601. PubMed ID: 31106499
[TBL] [Abstract][Full Text] [Related]
12. Opioid use disorder during pregnancy in Tennessee: expediency vs. science.
Martin PR; Finlayson AJ
Am J Drug Alcohol Abuse; 2015; 41(5):367-70. PubMed ID: 26186388
[TBL] [Abstract][Full Text] [Related]
13. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
14. The Pregnancy Recovery Center: A women-centered treatment program for pregnant and postpartum women with opioid use disorder.
Krans EE; Bobby S; England M; Gedekoh RH; Chang JC; Maguire B; Genday P; English DH
Addict Behav; 2018 Nov; 86():124-129. PubMed ID: 29884421
[TBL] [Abstract][Full Text] [Related]
15. Medication for Opioid Use Disorder During Pregnancy - Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014-2021.
Miele K; Kim SY; Jones R; Rembert JH; Wachman EM; Shrestha H; Henninger ML; Kimes TM; Schneider PD; Sivaloganathan V; Sward KA; Deshmukh VG; Sanjuan PM; Maxwell JR; Seligman NS; Caveglia S; Louis JM; Wright T; Bennett CC; Green C; George N; Gosdin L; Tran EL; Meaney-Delman D; Gilboa SM
MMWR Surveill Summ; 2023 May; 72(3):1-14. PubMed ID: 37130060
[TBL] [Abstract][Full Text] [Related]
16. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
17. Recent trends in treatment admissions for prescription opioid abuse during pregnancy.
Martin CE; Longinaker N; Terplan M
J Subst Abuse Treat; 2015 Jan; 48(1):37-42. PubMed ID: 25151440
[TBL] [Abstract][Full Text] [Related]
18. Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: A retrospective study of admissions to treatment centers in the United States.
Winkelman TNA; Ford BR; Shlafer RJ; McWilliams A; Admon LK; Patrick SW
PLoS Med; 2020 May; 17(5):e1003119. PubMed ID: 32421717
[TBL] [Abstract][Full Text] [Related]
19. Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
Holbrook AM
Am J Drug Alcohol Abuse; 2015; 41(5):371-3. PubMed ID: 26154531
[TBL] [Abstract][Full Text] [Related]
20. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
